The tumor microenvironment, including microbiome populations in the local niche of several types of solid tumors like mammary and colorectal cancer are distinct. The occurrence of one type of cancer over another varies from animals to human individuals. Further, clinical data suggest that specific cancer types such as mammary and colorectal cancer are rare in ruminant like goat.
In addition to the above problems, use of these current regimens of drugs is also faced with the social status of patients in developing countries like India where majority of current and future cancer patients are in the weaker economic strata of the society. Hence, viable, sustainable and cheaper source of anti-cancer drugs will be suitable options in Indian and other developing countries.
The role of tumor microenvironment directly and indirectly influenced by microbiotas residing in the local niche of tumor is seeking attention across the globe (Gill et Therefore, this paper is of the first attempt to understand Xeno-heterogeneity by comparative study on DNA metabolizing and anti-proliferative potential of the DMSO urine fraction of various ruminants including cow, goat, ox, horse, buffalo, jenny and human.
MATERIAL AND METHODOLOGY

Materials
Cell culture reagents were purchased from Invitrogen India Pvt. Ltd. and Himedia India Pvt.
Ltd. The HCT-116 and MCF-7 cells were procured from National Centre of Cell Science (NCCS), Pune, India. DMSO, pBR322 DNA, agarose, acrylamide and other chemicals were of analytical grade and obtained from Himedia India Pvt. Ltd and Merck India Pvt. Ltd. 
Preparation of UDF from various ruminants and human
Cell line maintenance and preparation of MCF-7 cells for genomic DNA isolation
The HCT-116 and MCF-7 cells were cultured and maintained in DMEM (Dulbecco's Modified Eagles Medium) (Himedia) with high glucose supplemented with 10% heat inactivated FBS/penicillin (100 units/ml)/streptomycin (100 µg/ml) at 37°C in a humidified 5% CO2 incubator. Further, 60-70% confluent MCF-7 cells were harvested and subjected to the genomic DNA isolation as modified protocol (Kumar et al., 2017; . After the isolation of genomic DNA from MCF-7 cells, the integrity and quality of genomic DNA was assessed using standard methods and stored at -20°C for in vitro DNA damaging ability assessment of UDF from various sources.
In Vitro DNA metabolizing assay
To assess the DNA metabolizing effects of UDF samples from ruminants and human, an in vitro reaction was set up. In this reaction mixture, 1 μl of pBR322 plasmid DNA (100 ng / μl), 1 μg of genomic DNA (MCF-7 breast cancer cells) were mixed with 2.5 μl each of TAE buffer (Triacetate/EDTA 10 mM, pH 7.4) and finally treated by different concentration of UDF samples of 1 μl (20 μg to 40 μg per ml) was added to the reaction mixture. The final volume of each reaction mixture was brought to 25 μl by the addition of nuclease free water in a micro centrifuge tube. 
Trypan blue dye exclusion assay
Here, HCT-116 and MCF-7 cells were plated in six well plate (1.5*105 cells per well) and incubated in the presence of complete fresh DMEM medium supplemented with 10% FBS. After 16-18 h, cells were treated with 2 ml of complete fresh DMEM medium and added with varied concentration (10, 50 and 100 µl/ml) final concentration of goat UDF sample (stock 10 mg per ml). (10, 50 and 100 µl/ml) final concentration. A negative control was also prepared by including complete fresh DMEM medium mixed with equal amount of DMSO solvent. After 72 h of incubation, the media was aspirated to recover the floating cells. Next, cells were washed with PBS and treated with 0.25% trypsin-EDTA for 2-3 min at 37ºC. Fresh media were added into each well and cells were harvested properly. To check the total and viable cell count in the collected cell suspensions, a routinely used Trypan blue dye exclusion was performed to estimate viable cell and dead cell using Hemocytometer.
STATISTICAL ANALYSIS
Data shown are presented as the mean ± SD of at least three independent experiments; differences are considered statistically significant at P < 0.05, using a Student's t-test.
RESULTS AND DISCUSSION
DNA metabolizing effects of UDF from various sources
In this paper, UDF samples from various ruminants and human are prepared and filtered in a sterile condition. Based on the literature, distinct intestinal microbiotas and potential diet derived metabolites are known to be distinct from each other. However, a simple assay to know the DNA metabolizing effects of these UDF composition is not reported and this assay may provide additional evidence in support of distinct of UDF samples among all these sources of urine samples.
To assess the DNA metabolizing effects of UDF samples, Figure 1A Similarly, Figure 2A represents a photograph of agarose gel electrophoresis-based separation of genomic DNA derived from MCF-7 breast cancer cells that is treated by UDF samples from various sources. The genomic DNA instability is analyzed using the band intensity densitometry analysis software and data is given as a bar graph in Fig. 2B . The analysis of data in Fig. 2B indicates highly appreciable genomic DNA degradation in the range of 80 to 90% goat UDF compared to UDF samples from other ruminants and human. Among many ruminants and human samples, cow UDF sample display to some extent of DNA metabolizing effects upon the genomic DNA, however, the pattern of DNA damage to genomic DNA is clearly distinct from goat UDF to cow UDF. In this data, it is mentioned that the amount of used UDF samples ranged from 20 to 40 µg per ml and the volume of UDF samples used in this reaction ranged from 0.5 µl to 1 µl per reaction volume. The observed differential DNA metabolizing effects of goat and cow UDF in comparison to other ruminants and human UDF samples is well explained by the presence of distinct metabolites in the isolated UDF samples from various ruminants and human. Importantly, DNA metabolizing effects of precisely goat and cow UDF can be attributed to majorly to metabolites and similar compounds as protein profile details do not support the presence of proteins and urea and this may be due to the nature of fractionation process and solvent DMSO that exclude the possibilities of urea, similar to urea and protein components.
In this reference, a concern is raised that goat UDF sample may contain some inorganic Further, a graphical representation of total HCT-116 cells and total viable HCT-116 cells is shown in Fig. 4B . The data clearly shows the highly significant decrease in the total number of HCT-cells and also the total number of viable HCT-116 cells. In essence, this cell based assay does not provides the information on the nature and type of cell death due to treatment by goat UDF. As earlier suggested by several other reports, Trypan blue dye exclusion assay provides information on anti-proliferative and anti-survival potentials, but may not be sufficient to reveal the kind of cell death and other cellular changes including cell cycle changes in treating cancer cells. In this paper, current preliminary data appears to be sound and reproducible to support the effects of goat UDF sample upon HCT-116 cells. Next, we tested the anti-proliferative effects upon other cell line MCF-7 cells, which is completely distinct from the HCT-116 cells in terms of genetic and molecular adaptations. In this way, the authors are interested to know that whether distinctive composition of goat UDF will display anti-proliferative effects upon any types of cancer cells. Surprisingly, data collected from using Trypan blue dye exclusion assay upon MCF-7 cells suggest that anti-proliferative efficacy of goat UDF is significantly less compared to HCT-116 cells (Fig. 5A and Fig. B ).
At this juncture of preliminary observations, we speculate that the distinctive goat UDF composition may have specific targets like nuclear receptor in the HCT-116 cells compared to MCF-7 cells, which may be able to contribute to better anti-proliferative effects in MCT-116.
Interestingly, rare occurrence of colorectal cancer in goat, unique microbial colonization of goat gut system, and derived metabolites in goat urine converge upon to indicate that the observed findings from in vitro anti-proliferative effects of goat UDF compared to UDF samples from other ruminants and human may have preclinical and clinical relevance. On the future road map, these goat UDF and other samples are in process of LC-MS analysis to confirm the chemical identities that may be a contributing factor in the observed findings in DNA metabolizing and anti-proliferative effects upon HCT-116 cells. Further, this finding may set the platform to investigate on goat UDF samples as potential novel potential anti-cancer pharmaceutical composition. The possible claim of this paper is well supported from the basic understanding of cancer biology that depicts cancer is highly complex and heterogeneous nature. In recent, tumor heterogeneity and various hallmarks such as drug resistance is well explained by the distinct heterogeneity at cellular levels that include various types of cells like immune cells, stromal cells, etc. Besides these known cells, presence of microbiotas in the local niche of tumor is well associated to the tumor hallmarks and tumor progression. Interestingly, different populations of microbiotas are reported to act as both tumor promoters and tumor inhibitors.
In a comprehensive review, various ruminants and human individuals are evidenced to display distinct gut microbiotas and related secreted metabolite profiles in urine samples from these sources. Our finding also supports that may be distinct gut microbiotas in various ruminants and as well distinct nutrition factors contribute towards differential urine metabolites and these urine metabolites show distinct activities as reported in this paper as DNA metabolizing effects of cow and goat UDF.
FUTURE DIRECTIONS
In future, studies can be conducted to validate the in vitro effects of goat UDF in colon cancer in mice model. In future, metabolites components of goat UDF can be combined with nano-carriers for better drug delivery. In a better quest, molecular targets like nuclear receptors of colorectal cancer cells may be explored as specific targets of metabolites components of goat UDF and further warrants study in both in vitro and in vivo colorectal cancer model.
SIGNIFICANCE STATEMENT
In this paper, the authors draw the attention to suggest that this simple finding is potentially linked to one of key question tumor heterogeneity in cancer biology. Here, findings propose that goat and other ruminants may have naturally equipped metabolic systems contributed by gut system, microbiotas in the local niche and dietary derived metabolites to thwart carcinogenesis process in goat. Conversely, human and other highly susceptible vertebrates may lack these antiproliferative and anti-cancer metabolites derived from gut system, microbiotas in the local niche and dietary derived metabolites. In essence, human and other highly susceptible vertebrates may generate pro-cancer and pro-carcinogenesis metabolites from gut system, microbiotas in the local niche and dietary derived metabolites. Taken together, this findings warrants other preclinical scientists to look into detailed mechanisms that may lead to the better understanding on tumor heterogeneity, revealing novel metabolite biomarkers and therapeutic interventions in future.
CONCLUSION:
In conclusion, goat UDF displays distinct abilities to metabolize plasmid and genomic DNA substrates. Further, goat UDF treatment to HCT-116 shows very strong anti-proliferative effects and warrants appreciable future investigations in vitro and in vivo model of colorectal cancer. Interestingly, goat UDF does bring similar extent of effects upon MCF-cells. It is important to conclude that goat UDF sample used for the present DNA metabolizing and antiproliferative assay is filter membrane sterilized. But, autoclaving of goat UDF sample shows the loss of both DNA metabolizing and anti-proliferative effects. This finding supports the one of the possible answer behind the xeno-tumor heterogeneity among ruminants and human idea that may establish definite connections with differential occurrence (rare in goat) and high occurrence (human). 
